Roundtable Discussion: The role of IVUS in Contemporary PCI

Roundtable Discussion

 
SESSION 3:The role of IVUS in prevention and assessment of PCI complications

PRESENTER

Dr Andrew Sharp
Consultant Interventional Cardiologist, working at the Royal Devon and Exeter Hospital in South West England.

PANEL

Prof Takashi Akasaka, Wakayama, Japan
Prof Carlo di Mario, Florence, Italy
Prof Jacek Legutko, Krakow, Poland
Dr Peter O'Kane, Bournemouth, UK

To aid our viewers to follow the topics discussed please see the following guidance:

Time Discussion Point Discussant
00.00-00.29 Introduction Sharp
00.29-03.58 Stent thrombosis Akasaka/Sharp/O'Kane
03.58-08.50 Dissection Legutko/Sharp
08.50-13.12 Under Expansion Di Mario/Sharp
13.12-17.48 Restenosis O'Kane/Sharp/Legutko
17.48-22.17 Development in the field Di Mario/Sharp/Akasaka
22.17-24.49 Session summary Sharp
Dr Andrew Sharp is a Consultant Interventional Cardiologist, working at the Royal Devon and Exeter Hospital in South West England.
Prof Takashi Akasaka graduated from Wakayama Medical University in 1982 and finished his residency at Kobe City Medical Center General Hospital.
Prof Carlo Di Mario is currently Professor of Clinical Cardiology, NHLI, Imperial College of Sciences, Medicine & Technology, London.
Prof Jacek Legutko graduated as a medical doctor in 1993 and has specialist degrees in both internal medicine and cardiology. His present appointments are as professor of medicine and interventional cardiologist at the Institute of Cardiology, Jagiellonian University Medical College, University Hospital in Krakow, Poland.
Dr Peter O’Kane qualified from Charing Cross and Westminster Medical School in 1995 and commenced specialty training in Cardiology as a research registrar at St Thomas’ Hospital in 1998.

The assigned learning objectives for this roundtable are listed for your information:

To increase awareness, understanding and adoption of IVUS technology

  • To educate on clinical utilisation of IVUS in specific indications
  • To review current clinical trial data and discuss gaps
  • To analyse use of IVUS in the assessment of complications

This educational activity is intended for an international audience, specifically interventional cardiologists and cardiologists. However, other healthcare professionals involved in the care of coronary artery disease (CAD) patients will also find this topical.